Aerolase® Nearly Doubles Its Revenues in 2011

Share Article

Aerolase®, the world leader in the miniaturization of high-powered medical lasers, is proud to announce their revenues have nearly doubled in 2011 as they continue to introduce more breakthrough laser technology in aesthetics and dermatology.

News Image
“Growth continues to be driven by the exceptional value proposition that LightPod™ lasers offer to the clinician, augmented by several emerging segments and applications.

This New York-based company is one of the fastest growing businesses in the aesthetic and dermatology laser systems space. In fact, Aerolase® just introduced the LightPod Forte™, a portable 1064nm laser for podiatry with more than a 90% success rate in efficacy in nail treatment. When applied to the foot or ankle, its gentle pulse coagulates soft tissue including warts, fungal material, vascular formations, telangiectasias (spider veins), scars, even tattoo reduction.

Aerolase® is a true heavyweight in the research and development arena in the aesthetics and dermatology fields. They continuously release new and innovative products that are effective and beneficial both to medical professionals and their patients. Due to its outstanding growth, this laser systems company has been adding new team members in their sales, marketing and operational departments to support its expansion and laser manufacturing capacities. “Growth continues to be driven by the exceptional value proposition that LightPod™ lasers offer to the clinician, augmented by several emerging segments and applications,” says Aerolase’s Chief Executive officer Paul Efremkin.

Aerolase® has been developing a new generation of medical aesthetic laser technology for quite some time now, transforming the medical office as well as medical spas. “Our unique products are unmatched in their blend of clinical efficacy, treatment versatility and low cost of ownership. These benefits appeal to existing laser owners who are looking to expand their service offerings and skin types treated. These also appeal to professionals looking to reduce operating costs versus their stationary water-cooled lasers, as well as those entering into laser therapy and are seeking a single laser system that delivers maximum financial returns,” explains Dr. Efremkin.

The company’s LightPod™ medical aesthetic lasers have received clearances by the FDA as early as 2001, as well as European and Canadian clearances in 2006. The clinical efficacies of their various products including the LightPod Era™, LigthPod Neo™ and LightPod Forte™ have been reported in peer-reviewed journals. The success of their laser systems is much attributed to their efficacy, treatment versatility, low cost, their portability, little or no maintenance and the benefits to patients such as fast results and far less treatment discomfort. Aerolase® truly represents a new era in compact, cost-effective performance for clinicians, aesthetic specialists and podiatrists in various environments from private practices to medical spas.

About Aerolase®: Founded in 1996, Aerolase® is the world leader in the miniaturization of high powered medical lasers such as the LightPod Forte™, LightPod Neo™ and the LightPod Era™. This laser technology company provides new levels of clinical versatility, practical utility and cost-effectiveness for all its clinicians and aesthetic specialists in podiatry, dermatology, cosmetic surgery, and aesthetics and rejuvenation. Aerolase® is continuously releasing new compact laser technology systems for a broad range of applications.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Hurley
Visit website